Similar articles for PMID: 28818991

Year	Number of Results
1985	1
1996	1
2000	1
2002	1
2003	3
2006	2
2008	1
2009	3
2012	3
2013	3
2014	3
2015	10
2016	12
2017	16
2018	11
2019	2
2020	8
2021	6
2022	2
2023	1
2024	0

1

Immune Modulation Therapy and Imaging: Workshop Report.

Shields AF, Jacobs PM, Sznol M, Graham MM, Germain RN, Lum LG, Jaffee EM, de Vries EGE, Nimmagadda S, Van den Abbeele AD, Leung DK, Wu AM, Sharon E, Shankar LK. Shields AF, et al. J Nucl Med. 2018 Mar;59(3):410-417. doi: 10.2967/jnumed.117.195610. Epub 2017 Aug 17. J Nucl Med. 2018. PMID: 28818991 Free PMC article.

2

Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.

Zanganeh S, Spitler R, Hutter G, Ho JQ, Pauliah M, Mahmoudi M. Zanganeh S, et al. Immunotherapy. 2017 Sep;9(10):819-835. doi: 10.2217/imt-2017-0041. Immunotherapy. 2017. PMID: 28877626 Review.

3

Imaging of tumour response to immunotherapy.

Dromain C, Beigelman C, Pozzessere C, Duran R, Digklia A. Dromain C, et al. Eur Radiol Exp. 2020 Jan 3;4(1):2. doi: 10.1186/s41747-019-0134-1. Eur Radiol Exp. 2020. PMID: 31900689 Free PMC article.

4

Immune-Directed Molecular Imaging Biomarkers.

Pandit-Taskar N, Postow MA. Pandit-Taskar N, et al. Semin Nucl Med. 2020 Nov;50(6):584-603. doi: 10.1053/j.semnuclmed.2020.06.005. Epub 2020 Jul 15. Semin Nucl Med. 2020. PMID: 33059826 Review.

5

Cancer Imaging in Immunotherapy.

Eleneen Y, Colen RR. Eleneen Y, et al. Adv Exp Med Biol. 2017;995:141-153. doi: 10.1007/978-3-319-53156-4_7. Adv Exp Med Biol. 2017. PMID: 28321816 Review.

6

Critical features and challenges associated with imaging in patients undergoing cancer immunotherapy.

Solinas C, Porcu M, Hlavata Z, De Silva P, Puzzoni M, Willard-Gallo K, Scartozzi M, Saba L. Solinas C, et al. Crit Rev Oncol Hematol. 2017 Dec;120:13-21. doi: 10.1016/j.critrevonc.2017.09.017. Epub 2017 Oct 10. Crit Rev Oncol Hematol. 2017. PMID: 29198327 Review.

7

Molecular imaging to enlighten cancer immunotherapies and underlying involved processes.

van der Veen EL, Bensch F, Glaudemans AWJM, Lub-de Hooge MN, de Vries EGE. van der Veen EL, et al. Cancer Treat Rev. 2018 Nov;70:232-244. doi: 10.1016/j.ctrv.2018.09.007. Epub 2018 Sep 25. Cancer Treat Rev. 2018. PMID: 30308466 Review.

8

Understanding Response to Immunotherapy Using Standard of Care and Experimental Imaging Approaches.

Flavell RR, Evans MJ, Villanueva-Meyer JE, Yom SS. Flavell RR, et al. Int J Radiat Oncol Biol Phys. 2020 Sep 1;108(1):242-257. doi: 10.1016/j.ijrobp.2020.06.025. Epub 2020 Jun 22. Int J Radiat Oncol Biol Phys. 2020. PMID: 32585333

9

PET imaging of cancer immunotherapy.

Tumeh PC, Radu CG, Ribas A. Tumeh PC, et al. J Nucl Med. 2008 Jun;49(6):865-8. doi: 10.2967/jnumed.108.051342. J Nucl Med. 2008. PMID: 18511842 Free article. Review.

10

In-vivo imaging of tumor-infiltrating immune cells: implications for cancer immunotherapy.

Zeelen C, Paus C, Draper D, Heskamp S, Signore A, Galli F, Griessinger CM, Aarntzen EH. Zeelen C, et al. Q J Nucl Med Mol Imaging. 2018 Mar;62(1):56-77. doi: 10.23736/S1824-4785.17.03052-7. Epub 2017 Nov 30. Q J Nucl Med Mol Imaging. 2018. PMID: 29191000 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

80 results

Results by year